[rev_slider alias=”jbs”]

About the Journal

INTRODUCTION

Biopharmaceutical Science involves study of the discovery, development and processing of modern, medical drugs by artificially growing some or all of the components utilising cell culture technologies. The processes involved are more biological-based as compared to the more chemical-based processes associated with small-molecule pharmaceutical products. The Medical Biotechnology and Biopharmaceutical sectors are among the fastest growing in the Life Sciences area both nationally and internationally.

They are proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) used for therapeutic or in vivo diagnostic purposes, and are produced by means other than direct extraction from a native (non-engineered) biological source. Biopharmaceuticals are medical drugs produced using biotechnology. They are proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) used for therapeutic or in vivo diagnostic purposes, and are produced by means other than direct extraction from a native (non-engineered) biological source. The first such substance approved for therapeutic use was recombinant human insulin (rHI, trade name Humulin), which was developed by Genentech and marketed by Eli Lily in 1982. The large majority of biopharmaceutical products are pharmaceuticals that are derived from life forms. Small molecule drugs are not typically regarded as biopharmaceutical in nature by the industry.

AIMS & SCOPE

Journal of Biopharmaceutics Sciences (ISSN: 2329-8200, eISSN: 2329-8197) provides a medium for publication of novel and innovative research from the areas of Pharmaceutical Technology, Pharmaceutical Biotechnology and Biopharmaceutics.

Topics covered include:

  • Drug and pro-drug design, drug stability and drug development
  • Development, formulation and manufacturing of pharmaceuticals and biopharmaceuticals
  • Physical pharmacy, drug delivery systems, controlled release systems and drug targeting
  • Biopharmaceutics
  • Pharmaceutical analysis and pharmaceutical packaging
  • Quality control, GMP and regulatory aspects
  • Medical devices

Peer Review Policy

All peer review is single blind and submission is online via Editorial Manager.

Article Publishing Charge

There is no APC from 2017 to 2020. Authors will pay $300 only from 2021 onwards.

Submission Charges

There are no submission charges for this journal.

0 %
ACCEPTANCE
0 days
FINAL DECISION
0 days
PUBLICATION
0 $
APC

Editorial Board

EDITOR IN CHIEF

Prof Nissar A Darmani
Western University of Health Sciences, United States

Prof Dr John Arnold Urban D’Souza
Department of Biomedical Sciences & Therapeutics
Faculty of Medicine & Health Sciences
University Malaysia Sabah
Kota Kinabalu, Sabah
Malaysia

EDITORIAL BOARD MEMBERS

Prof Sola Ricardo J.
Puerto Rico University, USA

Prof Shugarts Sarah
Calif San Francisco University, USA

Dr Dahan Arik
Michigan University, USA

Dr Sosnik, Alejandro
Buenos Aires University, Argentina

Dr Beig, Avital
Ben Gurion University, Israel

Prof Kortejarvi H.
University of Helsinki, Finland

Dr Rodrigues Carlos R.
Univ Fed Rio de Janeiro, Brazil

Prof Strauch Stefanie
University of Frankfurt, Germany

Prof Chen, Chia-Hao
National Taiwan University, Taiwan

Dr Mikhail G. Kolonin
University of Texas, USA

Prof Alexander D. Verin
Georgia Regents University, USA

Dr Edward J. Kim
University of California at Davis, USA

Prof Marco Matteo Ciccone
University of Bari, Italy

Dr John A. Roush
Virginia Tech, USA

Dr Mengmeng Wang
Pharmacodynamics and Metabolism,
Pfizer Inc., USA

Prof Gloria Marcela Rodriguez
Rutgers the State University of New Jersey, USA

Dr Christine DUFÈS
University of Strathclyde, Glasgow, UK

Dr M. Rami Reddy
University of North Carolina at Chapel Hill, USA

Dr Vibhor Gupta
University of Pennsylvania, Philadelphia, USA

Dr Edmond Dik-Lung MA
Hong Kong Baptist University, Hong Kong

Prof Liwu Fu
Sun Yat-sen University, Guangzhou, China

Dr Julian Thomas Pittman
Troy University, USA

Prof Shufeng Zhou
University of South Florida (USF), USA

Dr Samuel Clayton Wordeman
The Ohio State University, USA

Advisory Committee

Abstracting and Indexing

Article in Press

  1. OPTIMIZATION OF GEL BASED SYSTEM OF LERCANIDIPINE BY STATISTICAL DESIGN FOR TRANSDERMAL DELIVERY: HISTOPATHOLOGICAL EXAMINATION AND RHEOLOGICAL CHARACTERIZATION
    Yingli Zhang, Wen Li, Lianmei Du, Shuo Yin, Jiming Liu
  2. PREPARATION AND CHARACTERIZATION OF PUERARIN NANOSUSPENSION BY ANTI-SOLVENT PRECIPITATION
    Chongkai Gao Bohong Guo, Danqiao Xu, Jin Li, Yihua Chen, Xiaofang Li, Chenchen Jin, Keqing Zhang
  3. PROTECTIVE EFFECT OF SANSHEN WEIXIN CAPSULA ON CARDIAC FUNCTION OF RATS WITH HEART FAILURE FOLLOWING MYOCARDIAL INFARCTION
    Sun Liankun, Yang Xiaochun, Rao Yanwei, Zhang Yong, Lu Yuxiong, Su
  4. SIMULTANEOUS MULTIRESPONSE OPTIMIZATION OF THE MEDIUM FOR SUBMERGED FERMENTING IRPEX LACTEUS FR. MYCELIA USING DESIRABILITY FUNCTION
    Li-rong Teng, Jia Song, Lin-na Du, Jia-ming Cao, Jia-hui Lu, Qing-fan Meng
  5. TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION COMBINED WITH PERCUTANEOUS INJECTION OF ETHANOL-LIPIODOL MIXTURE FOR TREATMENT OF HEPATOCELLULAR CARCINOMA: A NON-RANDOMIZED CONTROLLED STUDY OF 122 CASES
    Zhang Min

Current Issue

No Content Download Pages
Editorial JBS
1 OPTIMIZATION OF GEL BASED SYSTEM OF LERCANIDIPINE BY STATISTICAL DESIGN FOR TRANSDERMAL DELIVERY: HISTOPATHOLOGICAL EXAMINATION AND RHEOLOGICAL CHARACTERIZATION
Kanchan Kohli, Nafees Ahmad, Raziyeh Afzali, Yub Raj Neupane, Saima Amin
DOI : 10.26480/jbs.02.2017.01.09
Visitor download : [download_data id=”3857″ data=”download_count”]
1-9
2 PREPARATION AND CHARACTERIZATION OF PUERARIN NANOSUSPENSION BY ANTI-SOLVENT PRECIPITATION
Chongkai Gao Bohong Guo, Danqiao Xu, Jin Li, Yihua Chen, Xiaofang Li, Chenchen Jin, Keqing Zhang
DOI : 10.26480/jbs.02.2017.10.14
Visitor download : [download_data id=”3858″ data=”download_count”]
10-14
3 PROTECTIVE EFFECT OF SANSHEN WEIXIN CAPSULA ON CARDIAC FUNCTION OF RATS WITH HEART FAILURE FOLLOWING MYOCARDIAL INFARCTION
Sun Liankun, Yang Xiaochun, Rao Yanwei, Zhang Yong, Lu Yuxiong, Su
DOI : 10.26480/jbs.01.2017.10.13
Visitor download : [download_data id=”3862″ data=”download_count”]
15-19
4 SIMULTANEOUS MULTIRESPONSE OPTIMIZATION OF THE MEDIUM FOR SUBMERGED FERMENTING IRPEX LACTEUS FR. MYCELIA USING DESIRABILITY FUNCTION
Li-rong Teng, Jia Song, Lin-na Du, Jia-ming Cao, Jia-hui Lu, Qing-fan Meng
DOI : 10.26480/jbs.02.2017.20.24
Visitor download : [download_data id=”3861″ data=”download_count”]
20-24
5 TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION COMBINED WITH PERCUTANEOUS
INJECTION OF ETHANOL-LIPIODOL MIXTURE FOR TREATMENT OF HEPATOCELLULAR CARCINOMA: A NON-RANDOMIZED CONTROLLED STUDY OF 122 CASES
Zhang Min
DOI : 10.26480/jbs.02.2017.25.28
Visitor download : [download_data id=”3865″ data=”download_count”]
25-28

Archives

2017, Volume 1, Issue 2

No Content Download Pages
Editorial JBS
1 OPTIMIZATION OF GEL BASED SYSTEM OF LERCANIDIPINE BY STATISTICAL DESIGN FOR TRANSDERMAL DELIVERY: HISTOPATHOLOGICAL EXAMINATION AND RHEOLOGICAL CHARACTERIZATION
Kanchan Kohli, Nafees Ahmad, Raziyeh Afzali, Yub Raj Neupane, Saima Amin
DOI : 10.26480/jbs.02.2017.01.09
Visitor download : [download_data id=”3857″ data=”download_count”]
1-9
2 PREPARATION AND CHARACTERIZATION OF PUERARIN NANOSUSPENSION BY ANTI-SOLVENT PRECIPITATION
Chongkai Gao Bohong Guo, Danqiao Xu, Jin Li, Yihua Chen, Xiaofang Li, Chenchen Jin, Keqing Zhang
DOI : 10.26480/jbs.02.2017.10.14
Visitor download : [download_data id=”3858″ data=”download_count”]
10-14
3 PROTECTIVE EFFECT OF SANSHEN WEIXIN CAPSULA ON CARDIAC FUNCTION OF RATS WITH HEART FAILURE FOLLOWING MYOCARDIAL INFARCTION
Sun Liankun, Yang Xiaochun, Rao Yanwei, Zhang Yong, Lu Yuxiong, Su
DOI : 10.26480/jbs.01.2017.10.13
Visitor download : [download_data id=”3862″ data=”download_count”]
15-19
4 SIMULTANEOUS MULTIRESPONSE OPTIMIZATION OF THE MEDIUM FOR SUBMERGED FERMENTING IRPEX LACTEUS FR. MYCELIA USING DESIRABILITY FUNCTION
Li-rong Teng, Jia Song, Lin-na Du, Jia-ming Cao, Jia-hui Lu, Qing-fan Meng
DOI : 10.26480/jbs.02.2017.20.24
Visitor download : [download_data id=”3861″ data=”download_count”]
20-24
5 TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION COMBINED WITH PERCUTANEOUS
INJECTION OF ETHANOL-LIPIODOL MIXTURE FOR TREATMENT OF HEPATOCELLULAR CARCINOMA: A NON-RANDOMIZED CONTROLLED STUDY OF 122 CASES
Zhang Min
DOI : 10.26480/jbs.02.2017.25.28
Visitor download : [download_data id=”3865″ data=”download_count”]
25-28

2017, Volume 1, Issue 1

No Content Download Pages
Editorial JBS
1 AN ATOMIC FORCE MICROSCOPE EVALUATION OF DENTAL EANAMEL SURFACE STRUCTURE FOLLOWING BEYOND COLD-LIGHT BLEACHING AND CPP-ACP TREATMENT
Yingli Zhang, Wen Li, Lianmei Du, Shuo Yin, Jiming Liu
DOI : 10.26480/jbs.01.2017.01.04
Visitor download : [download_data id=”3847″ data=”download_count”]
1-4
2 DEVELOPMENT OF PHARMACEUTICAL FOAM BASED TOPICAL DRUG DELIVERY SYSTEM
Meghana S. Kamble, Sandhya P. Sutar, Saurabh A. Shinde, Pravin D. Chaudhari, Ashok V. Bhosale, Basavaraj K. Nanjwade
DOI : 10.26480/jbs.01.2017.05.09
Visitor download : [download_data id=”3849″ data=”download_count”]
5-9
3 EXPERIMENTAL STUDY ON THE CIRCUMFERENTIAL RESIDUAL STRAINS IN AORTIC ARCH BASED ON CURVE LENGTH METHOD
Zhang Xiaojun, Li Xiaoyang
DOI : 10.26480/jbs.01.2017.10.13
Visitor download : [download_data id=”3850″ data=”download_count”]
10-13
4 INDEX COMPOSITION CHANGE AND FINGER-PRINT CHROMATOGRAPHY ESTABLISHMENT IN THE HONEYSUCKLE PROCESSING COURSE
Jianjun Li, Meiling Ren, Guolun Jia, Jianqiang Liang, Baobin Liu
DOI : 10.26480/jbs.01.2017.14.19
Visitor download : [download_data id=”3853″ data=”download_count”]
14-19
5 MOLECULAR CHARACTERISATION AND DISSOLUTION PROFILE OF SOLID FORMULATIONS OF METFORMIN
K. Anand Solomon, J. Satyanarayana Reddy, B.N.Vedhahari
DOI : 10.26480/jbs.01.2017.20.24
Visitor download : [download_data id=”3854″ data=”download_count”]
20-24

Guide For Authors

Submission Checklist

You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Guide for Authors for more details.
Ensure that the following items are present:

  1. One author has been designated as the corresponding author with contact details:
    • E-mail address
    • Full postal address
  2. All necessary files have been uploaded:
    1. Manuscript:
      • Include keywords
      • All figures (include relevant captions)
      • All tables (including titles, description, footnotes)
      • Ensure all figure and table citations in the text match the files provided
      • Indicate clearly if color should be used for any figures in print
      • Graphical Abstracts / Highlights files (where applicable)
      • Supplemental files (where applicable)
    2. Further considerations:
      • Manuscript has been ‘spell checked’ and ‘grammar checked’
      • All references mentioned in the Reference List are cited in the text, and vice versa
      • Permission has been obtained for use of copyrighted material from other sources (including the Internet)
      • A competing interests statement is provided, even if the authors have no competing interests to declare
      • Journal policies detailed in this guide have been reviewed
      • Referee suggestions and contact details provided, based on journal requirements

For further information, visit our Support Center.

BEFORE YOU BEGIN

Ethics in publishing

The journal and its editorial board fully adhere and comply to the policies and principles of Committee on Publication Ethics (COPE) and this journal is a full member of Committee on Publication Ethics (COPE). For information on Ethics in publishing and Ethical guidelines for journal publication see https://publicationethics.org/guidance/Guidelines

Declaration of interest

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding.

Submission declaration and verification

Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis, see ‘Multiple, redundant or concurrent publication’ for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright holder. To verify originality, your article may be checked by the originality detection service Crossref Similarity Check.

Use of inclusive language

Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Articles should make no assumptions about the beliefs or commitments of any reader, should contain nothing which might imply that one individual is superior to another on the grounds of race, sex, culture or any other characteristic, and should use inclusive language throughout. Authors should ensure that writing is free from bias, for instance by using ‘he or she’, ‘his/her’ instead of ‘he’ or ‘his’, and by making use of job titles that are free of stereotyping (e.g. ‘chairperson’ instead of ‘chairman’ and ‘flight attendant’ instead of ‘stewardess’).

Contributors

Each author is required to declare his or her individual contribution to the article: all authors must have materially participated in the research and/or article preparation, so roles for all authors should be described. The statement that all authors have approved the final article should be true and included in the disclosure.

Changes to authorship

Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. An addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, the Editor must receive the following from the corresponding author: (a) the reason for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed.

Only in exceptional circumstances will the Editor consider the addition, deletion or rearrangement of authors after the manuscript has been accepted. While the Editor considers the request, publication of the manuscript will be suspended. If the manuscript has already been published in an online issue, any requests approved by the Editor will result in a corrigendum.

Author rights

Describes the rights related to the publication and distribution of research. It governs how authors (as well as their employers or funders), publishers and the wider general public can use, publish and distribute articles or books. As an author you (or your employer or institution) have certain rights to reuse your work.

Authors sign an exclusive license agreement, where authors have copyright but license exclusive rights in their article to the Zibeline International. In this case authors have the right to:

  1. Share their article in the same ways permitted to third parties under the relevant user license (together with Personal Use rights) so long as it contains a CrossMark logo, the end user license, and a DOI link.
  2. Retain patent, trademark and other intellectual property rights (including research data).
  3. Proper attribution and credit for the published work.

Role of the funding source

You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated.

Open access

All Zibeline International journals publish in open access modal: all articles will be immediately and permanently free for everyone to read and download. All articles will be published under the following license:

  1. Creative Commons Attribution – (CC BY)
  2. For non-commercial purposes, lets others distribute and copy the article, and to include in a collective work (such as an anthology), as long as they credit the author(s) and provided they do not alter or modify the article

Language (usage and editing services)

Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service available from ZI Editage.

Submission

Our online submission system guides you stepwise through the process of entering your article details and uploading your files. The system converts your article files to a single PDF file used in the peer review process. Editable files (e.g., Word, LaTeX) are required to typeset your article for final publication. All correspondence, including notification of the Editor’s decision and requests for revision, is sent by e-mail.

Submit your article

Please submit your article via https://www.journalonweb.com/ajmr/

Referees

Please submit the names and institutional e-mail addresses of several potential referees. For more details, visit our Support site. Note that the editor retains the sole right to decide whether or not the suggested reviewers are used.

Important notice

Multi-part papers are not to be considered. Papers that are requested by the editors to be revised must be returned within 4 weeks or they will be regarded as withdrawn.

PREPARATION

Peer review

This journal operates a blind review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor’s decision is final. More information on types of peer review.

Single-blind review

Zibeline journals uses single-blind review. More information is available on our website. To facilitate this, please include the following:

First page (with author details): This should include the title, authors’ names, affiliations, acknowledgements and any Declaration of Interest statement, and a complete address for the corresponding author including an e-mail address.

Use of word processing software

It is important that the file be saved in the native format of the word processor used. The text should be in single-column format. Keep the layout of the text as simple as possible. Most formatting codes will be removed and replaced on processing the article. In particular, do not use the word processor’s options to justify text or to hyphenate words. However, do use bold face, italics, subscripts, superscripts etc. When preparing tables, if you are using a table grid, use only one grid for each individual table and not a grid for each row. If no grid is used, use tabs, not spaces, to align columns. The electronic text should be prepared in a way very similar to that of conventional manuscripts. Note that source files of figures, tables and text graphics will be required whether or not you embed your figures in the text. See also the section on Electronic artwork.

To avoid unnecessary errors, you are strongly advised to use the ‘spell-check’ and ‘grammar-check’ functions of your word processor.

Article structure

  1. Subdivision – numbered sections
    Divide your article into clearly defined and numbered sections. Subsections should be numbered 1.1 (then 1.1.1, 1.1.2, …), 1.2, etc. (the abstract is not included in section numbering). Use this numbering also for internal cross-referencing: do not just refer to ‘the text’. Any subsection may be given a brief heading. Each heading should appear on its own separate line.
  2. Introduction
    State the objectives of the work and provide an adequate background, avoiding a detailed literature survey or a summary of the results.
  3. Material and methods
    Provide sufficient details to allow the work to be reproduced by an independent researcher. Methods that are already published should be summarized, and indicated by a reference. If quoting directly from a previously published method, use quotation marks and also cite the source. Any modifications to existing methods should also be described.
  4. Results
    Results should be clear and concise.
  5. Discussion
    This should explore the significance of the results of the work, not repeat them. A combined Results and Discussion section is often appropriate. Avoid extensive citations and discussion of published literature.
  6. Conclusions
    The main conclusions of the study may be presented in a short Conclusions section, which may stand alone or form a subsection of a Discussion or Results and Discussion section.
  7. Appendices
    If there is more than one appendix, they should be identified as A, B, etc. Formulae and equations in appendices should be given separate numbering: Eq. (A.1), Eq. (A.2), etc.; in a subsequent appendix, Eq. (B.1) and so on. Similarly for tables and figures: Table A.1; Fig. A.1, etc.
  8. Essential first page information
    • Title. Concise and informative. Titles are often used in information-retrieval systems. Avoid abbreviations and formulae where possible.
    • Author names and affiliations. Please clearly indicate the given name(s) and family name(s) of each author and check that all names are accurately spelled. You can add your name between parentheses in your own script behind the English transliteration. Present the authors’ affiliation addresses (where the actual work was done) below the names. Indicate all affiliations with a lowercase superscript letter immediately after the author’s name and in front of the appropriate address.Provide the full postal address of each affiliation, including the country name and, if available, the e-mail address of each author.
    • Corresponding author. Clearly indicate who will handle correspondence at all stages of refereeing and publication, also post-publication. This responsibility includes answering any future queries about Methodology and Materials. Ensure that the e-mail address is given and that contact details are kept up to date by the corresponding author.
    • Present/permanent address. If an author has moved since the work described in the article was done, or was visiting at the time, a ‘Present address’ (or ‘Permanent address’) may be indicated as a footnote to that author’s name. The address at which the author actually did the work must be retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.
  9. Abstract
    A concise and factual abstract is required. The abstract should state briefly the purpose of the research, the principal results and major conclusions. An abstract is often presented separately from the article, so it must be able to stand alone. For this reason, References should be avoided, but if essential, then cite the author(s) and year(s). Also, non-standard or uncommon abbreviations should be avoided, but if essential they must be defined at their first mention in the abstract itself.
  10. Keywords
    Immediately after the abstract, provide a maximum of 6 keywords, using American spelling and avoiding general and plural terms and multiple concepts (avoid, for example, ‘and’, ‘of’). Be sparing with abbreviations: only abbreviations firmly established in the field may be eligible. These keywords will be used for indexing purposes.
  11. Abbreviations
    Define abbreviations that are not standard in this field in a footnote to be placed on the first page of the article. Such abbreviations that are unavoidable in the abstract must be defined at their first mention there, as well as in the footnote. Ensure consistency of abbreviations throughout the article.
  12. Acknowledgements
    Collate acknowledgements in a separate section at the end of the article before the references and do not, therefore, include them on the title page, as a footnote to the title or otherwise. List here those individuals who provided help during the research (e.g., providing language help, writing assistance or proof reading the article, etc.).
  13. Formatting of funding sources
    List funding sources in this standard way to facilitate compliance to funder’s requirements: Funding: This work was supported by the National Institutes of Health [grant numbers xxxx, yyyy]; the Bill & Melinda Gates Foundation, Seattle, WA [grant number zzzz]; and the United States Institutes of Peace [grant number aaaa].It is not necessary to include detailed descriptions on the program or type of grants and awards. When funding is from a block grant or other resources available to a university, college, or other research institution, submit the name of the institute or organization that provided the funding. If no funding has been provided for the research, please include the following sentence:
    This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Artwork

  1. Electronic artwork
    1. General points
      • Make sure you use uniform lettering and sizing of your original artwork.
      • Embed the used fonts if the application provides that option.
      • Aim to use the following fonts in your illustrations: Arial, Courier, Times New Roman, Symbol, or use fonts that look similar.
      • Number the illustrations according to their sequence in the text.
      • Use a logical naming convention for your artwork files.
      • Provide captions to illustrations separately.
      • Size the illustrations close to the desired dimensions of the published version.
      • Submit each illustration as a separate file.
      • Ensure that color images are accessible to all, including those with impaired color vision.
    2. Formats
      • If your electronic artwork is created in a Microsoft Office application (Word, PowerPoint, Excel) then please supply ‘as is’ in the native document format.
      • Regardless of the application used other than Microsoft Office, when your electronic artwork is finalized, please ‘Save as’ or convert the images to one of the following formats (note the resolution requirements for line drawings, halftones, and line/halftone combinations given below):
        1. EPS (or PDF): Vector drawings, embed all used fonts.
        2. TIFF (or JPEG): Color or grayscale photographs (halftones), keep to a minimum of 300 dpi.
        3. TIFF (or JPEG): Combinations bitmapped line/half-tone (color or grayscale), keep to a minimum of 500 dpi.
    3. Please do not:
      1. Supply files that are optimized for screen use (e.g., GIF, BMP, PICT, WPG); these typically have a low number of pixels and limited set of colors;
      2. Supply files that are too low in resolution;
      3. Submit graphics that are disproportionately large for the content.
  2. Color artwork
    Please make sure that artwork files are in an acceptable format (TIFF, EPS or MS Office files) and with the correct resolution. If, together with your accepted article, you submit usable color figures these will be reproduced in color at no cost.

Figure captions

Ensure that each illustration has a caption. Supply captions separately, not attached to the figure caption should comprise a brief title (not on the figure itself) and a description of the illustration. Keep text in the illustrations themselves to a minimum but explain all symbols and abbreviations used.

Tables

Please submit tables as editable text and not as images. Tables can be placed either next to the relevant text in the article, or on separate page(s) at the end. Number tables consecutively in accordance with their appearance in the text and place any table notes below the table body. Be sparing in the use of tables and ensure that the data presented in them do not duplicate results described elsewhere in the article. Please avoid using vertical rules and shading in table cells.

References

  1. Citation in text
    Please ensure that every reference cited in the text is also present in the reference list (and vice versa). Any references cited in the abstract must be given in full. Unpublished results and personal communications are not recommended in the reference list, but may be mentioned in the text. If these references are included in the reference list they should follow the standard reference style of the journal and should include a substitution of the publication date with either ‘Unpublished results’ or ‘Personal communication’. Citation of a reference as ‘in press’ implies that the item has been accepted for publication.
  2. Web references
    As a minimum, the full URL should be given and the date when the reference was last accessed. Any further information, if known (DOI, author names, dates, reference to a source publication, etc.), should also be given. Web references can be listed separately (e.g., after the reference list) under a different heading if desired, or can be included in the reference list.
  3. Data references
    Zibeline journals encourages you to cite underlying or relevant datasets in your manuscript by citing them in your text and including a data reference in your Reference List. Data references should include the following elements: author name(s), dataset title, data repository, version (where available), year, and global persistent identifier. Add [dataset] immediately before the reference so we can properly identify it as a data reference. The [dataset] identifier will not appear in your published article.
  4. References in a special issue
    Please ensure that the words ‘this issue’ are added to any references in the list (and any citations in the text) to other articles in the same Special Issue.
  5. Reference style

    Text: All citations in the text should refer to:

    1. Single author: the author’s name (without initials, unless there is ambiguity) and the year of publication;
    2. Two authors: both authors’ names and the year of publication;
    3. Three or more authors: first author’s name followed by ‘et al.’ and the year of publication. Citations may be made directly (or parenthetically). Groups of references can be listed either first alphabetically, then chronologically, or vice versa.
  6. Examples: ‘as demonstrated (Allan, 2000a, 2000b, 1999; Allan and Jones, 1999)…. Or, as demonstrated (Jones, 1999; Allan, 2000)… Kramer et al. (2010) have recently shown …’
  7. List: References should be arranged first alphabetically and then further sorted chronologically if necessary. More than one reference from the same author(s) in the same year must be identified by the letters ‘a’, ‘b’, ‘c’, etc., placed after the year of publication.
  8. Examples:
    • Reference to a journal publication:
      Van der Geer, J., Hanraads, J.A.J., Lupton, R.A., 2010. The art of writing a scientific article. J. Sci. Commun. 163, 51–59. https://doi.org/10.1016/j.Sc.2010.00372.
    • Reference to a journal publication with an article number:
      Van der Geer, J., Hanraads, J.A.J., Lupton, R.A., 2018. The art of writing a scientific article. Heliyon. 19, e00205. https://doi.org/10.1016/j.heliyon.2018.e00205.
    • Reference to a book:
      Strunk Jr., W., White, E.B., 2000. The Elements of Style, fourth ed. Longman, New York.
    • Reference to a chapter in an edited book:
      Mettam, G.R., Adams, L.B., 2009. How to prepare an electronic version of your article, in: Jones, B.S., Smith, R.Z. (Eds.), Introduction to the Electronic Age. E-Publishing Inc., New York, pp. 281–304.
    • Reference to a website:
      Cancer Research UK, 1975. Cancer statistics reports for the UK (accessed 13 March 2003).
    • Reference to a dataset:
      [dataset] Oguro, M., Imahiro, S., Saito, S., Nakashizuka, T., 2015. Mortality data for Japanese oak wilt disease and surrounding forest compositions. Mendeley Data, v1.

Supplementary material

Supplementary material such as applications, images and sound clips, can be published with your article to enhance it. Submitted supplementary items are published exactly as they are received (Excel or PowerPoint files will appear as such online). Please submit your material together with the article and supply a concise, descriptive caption for each supplementary file. If you wish to make changes to supplementary material during any stage of the process, please make sure to provide an updated file. Do not annotate any corrections on a previous version. Please switch off the ‘Track Changes’ option in Microsoft Office files as these will appear in the published version.

AFTER ACCEPTANCE

Online proof correction

Corresponding authors will receive an e-mail with a link to our online proofing system, allowing annotation and correction of proofs online. The environment is similar to MS Word: in addition to editing text, you can also comment on figures/tables and answer questions from the Copy Editor.

Web-based proofing provides a faster and less error-prone process by allowing you to directly type your corrections, eliminating the potential introduction of errors. If preferred, you can still choose to annotate and upload your edits on the PDF version. All instructions for proofing will be given in the e-mail we send to authors, including alternative methods to the online version and PDF.

We will do everything possible to get your article published quickly and accurately. Please use this proof only for checking the typesetting, editing, completeness and correctness of the text, tables and figures. Significant changes to the article as accepted for publication will only be considered at this stage with permission from the Editor. It is important to ensure that all corrections are sent back to us in one communication. Please check carefully before replying, as inclusion of any subsequent corrections cannot be guaranteed. Proofreading is solely your responsibility.

Offprints

The corresponding author will be notified and receive a link to the published version of the open access article on journal website. This link is in the form of an article DOI link which can be shared via email and social networks. For an extra charge, paper offprints can be ordered via the offprint order form which is sent once the article is accepted for publication. Both corresponding and co-authors may order offprints at any time via Zibeline’s Author Services.

Author Inquiries

Author can inquire directly at our front help desk anytime using this email [email protected] and our office line number are available during working hours Asia Pacific standard time

© Copyright 2020 Volkson Press | www.volksonpress.com

Publication Ethics

VOLKSON PRESS publication ethics and publication malpractice statement is mainly based on the Committee of Publication Ethics’ (COPE) Code of Conduct and Best-Practice Guidelines (Committee on Publication Ethics, 2011).

Editor's Responsibilities

In addition to many general duties, such as constantly improving the quality and integrity of the journal, striving to needs of authors and readers, encouraging academic debate, and others, the editors accept obligation to apply best will and practice to cope with the following responsibilities:

Editorial Board
Editorial board will be generated from recognized experts in the field. The editor will provide full names and affiliations of the members as well as updated contact information for the editorial office on the journal webpage.

Publication decisions
The editor should be responsible for deciding which of the articles submitted to the journal should be published. The validation of the work in question and its importance to researchers and readers must always drive such decisions. The editor may be guided by the policies of the journal’s editorial board and constrained by such legal requirements, copyright infringement and plagiarism. The editor may confer with other editors or reviewers in making this decision.

Peer review process
All of a journal’s content should be subjected to peer-review. Articles submitted for possible publication are subjected to a double-blind, peer review process. Articles are first reviewed by editors. The editor may reject it out of hand either because it is not dealing with the subject matter for that journal or because it is manifestly of a low quality so that it cannot be considered at all. Articles that are found suitable for review are then sent to two experts in the field of the paper. Referees of a paper are unknown to each other. Referees are asked to classify the paper as publishable immediately, publishable with amendments and improvements, or not publishable. Referees’ evaluations usually include an explicit recommendation of what to do with the manuscript. Referees’ comments are then seen by the author.

Editors should be ready to justify any important deviation from the described process. Editors should not reverse decisions on publication unless serious problems are identified.

Editors should publish guidance to either authors and reviewers on everything that is expected of them. This guidance should be regularly updated and will refer or link this code.

Fair play
Editor should evaluate manuscripts for their intellectual content without regard to race, gender, sexual orientation, religious belief, ethnic origin, citizenship, or political philosophy of the authors. Editors´ decision to accept or reject a paper for publication should be based only on the paper´s importance, originality and clarity, and the study´s relevance to the aim of journal.

Digital Archiving
The editor will ensure digital preservation of access to the journal content by the Czech National Library within its WebArchive.

Confidentiality
Editor and any editorial staff must not disclose any information about a submitted manuscript to anyone other than the corresponding author, reviewers, potential reviewers, other editorial advisers, and the publisher. Editors will ensure that material submitted remains confidential while under review.

Disclosure and conflicts of interest
Unpublished materials disclosed in a submitted manuscript must not be used in an editor’s own research without the express written consent of the author. Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage. Editors should recuse themselves (i.e. should ask a co-editor, associate editor or other member of the editorial board instead to review and consider) from considering manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or (possibly) institutions connected to the papers. Editors should require all contributors to disclose relevant competing interests and publish corrections if competing interests are revealed after publication.

Procedures for dealing with unethical behavior
Unethical behavior may be identified and brought to the attention of the editor and publisher at any time, by anyone. Whoever informs the editor or publisher of such conduct should provide sufficient information and evidence in order for an investigation to be initiated. All allegations should be taken seriously and treated in the same way, until a successful decision or conclusion is reached. Every reported act of unethical publishing behavior must be looked into, even if it is discovered years after publication.

The editor should take reasonably responsive measures when ethical complaints have been presented concerning a submitted manuscript or published paper, in conjunction with the publisher. Such measures will generally include contacting the author of the manuscript or paper and giving due consideration of the respective complaint or claims made, but may also include further communications to the relevant institutions and research bodies, depending on the misconduct seriousness.

Minor misconduct might be dealt with without the need to consult more widely. In any event, the author should be given the opportunity to respond to any allegations.

Serious misconduct might require application of one or more following measures:

  1. Informing or educating the author or reviewer where there appears to be a misunderstanding or misapplication of acceptable standards.
  2. Publication of a formal notice detailing the misconduct.
  3. A formal letter to the head of the author’s or reviewer’s department or funding agency.
  4. Formal retraction or withdrawal of a publication from the journal, in conjunction with informing the head of the author or reviewer’s department
  5. Imposition of a formal embargo on contributions from an individual for a defined period.

Reviewer's Responsibilities

Contribution to editorial decisions
The peer-reviewing process assists the editor and the editorial board in making editorial decisions and may also serve the author in improving the paper.

Promptness
Any selected referee who feels unqualified to review the research reported in a manuscript or knows that its prompt review will be impossible should notify the editor and withdraw from the review process.

Confidentiality
Any manuscripts received for review must be treated as confidential documents. They must not be disclosed to or discussed with others except as authorized by the editor.

Standards of objectivity
Reviews should be conducted objectively. Personal criticism of the author is inappropriate. Referees should express their views clearly with supporting arguments.

Acknowledgement of sources
Reviewers should identify cases in which relevant published work referred to in the paper has not been cited in the reference section. They should point out whether observations or arguments derived from other publications are accompanied by the respective source. Reviewers will notify the editor of any substantial similarity or overlap between the manuscript under consideration and any other published paper of which they have personal knowledge.

Disclosure and conflict of interest
Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage. Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions associated with the papers.

Author's Responsibilities

Publication and Submission fee
No fees or charges are required from authors for manuscript processing. Authors pay neither submission nor publication fee beyond eventual conference registration fee. Full information about fees must be clearly stated on the journal´s website before authors begin preparing thein manuscript for submission.

Open Access Policy
The journal is freely available online. Authors are required to agree with this open access policy which enables unrestricted access and reuse of all published articles. The articles are published under the Creative Commons copyright license policy CC-BY. Users are allowed to copy and redistribute the material in printed or electronic format and build upon the material, without further permission or fees being required, provided that appropriate credit is given.

Reporting standards
Authors of papers should present an accurate account of the work performed as well as an objective discussion of its significance. Underlying data should be represented accurately in the paper. A paper should contain sufficient detail and references to permit others to replicate the work. Fraudulent or knowingly inaccurate statements constitute unethical behaviour and are unacceptable. Review and professional publication articles should also be accurate and objective, and editorial „opinion‟ works should be clearly identified as such.

Data access and retention
Authors may be asked to provide the raw data in connection with a paper for editorial review, and should be prepared to provide public access to such data (consistent with the ALPSP-STM Statement on Data and Databases), if practicable, and should in any event be prepared to retain such data for a reasonable time after publication.

Originality and plagiarism
The authors should ensure that they have written entirely original works, and if the authors have used the work and/or words of others, that this has been appropriately cited or quoted.

Plagiarism takes many forms, from “passing off” another´s paper as the author´s own paper, to copying or paraphrasing substantial parts of another´s paper (without attribution), to claiming results from research conducted by others. Plagiarism in all its forms constitutes unethical publishing behaviour and is unacceptable.

Multiple, redundant or concurrent publication
An author should not in general publish manuscripts describing essentially the same research in more than one journal or primary publication. Submitting the same manuscript to more than one journal concurrently constitutes unethical publishing behaviour. In general, an author should not submit for consideration in another journal a previously published paper.

The copyright remains with the authors (CC-BY), thus they can decide about eventual republication of their text. The primary reference must be cited in the secondary publication.

Acknowledgement of sources
Proper acknowledgment of the work of others must always be given. Authors should cite publications that have been influential in determining the nature of the reported work. Information obtained privately, as in conversation, correspondence, or discussion with third parties, must not be used or reported without explicit, written permission from the source. Information obtained in the course of confidential services, such as refereeing manuscripts or grant applications, must not be used without the explicit written permission of the author of the work involved in these services.

Authorship of the paper
Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. All those who have made significant contributions should be listed as co-authors. Where there are others who have participated in certain substantive aspects of the research project, they should be acknowledged or listed as contributors. The corresponding author should ensure that all appropriate co-authors and no inappropriate co-authors are included on the paper, and that all co-authors have seen and approved the final version of the paper and have agreed to its submission for publication.

Disclosure and conflicts of interest
All authors should disclose in their manuscript any financial or other substantive conflict of interest that might be construed to influence the results or interpretation of their manuscript. All sources of financial support for the project should be disclosed. Examples of potential conflicts of interest which should be disclosed include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Potential conflicts of interest should be disclosed at the earliest stage possible. Readers should be informed about who has funded research and on the role of the funders in the research.

Fundamental errors in published works
When an author discovers a significant error or inaccuracy in his/her own published work, it is the author´s obligation to promptly notify the journal editor or publisher and cooperate with the editor to retract or correct the paper. If the editor or the publisher learns from a third party that a published work contains a significant error, it is the obligation of the author to promptly retract or correct the paper or provide evidence to the editor of the correctness of the original paper.

Publisher's Responsibilities

As publisher VOLKSON PRESS provides practical support to the editor and executive editorial board of VOLKSON PRESS Journals so that they can follow the COPE Code of Conduct for their respective Journal;

  1. ensures the autonomy of editorial decisions;
  2. protects intellectual property and copyright;

ensures that good practice is maintained to the standards defined above.

References
Committee on Publication Ethics (COPE). (2011, March 7). Code of Conduct and Best-Practice
Guidelines for Journal Editors. Retrieved from
http://publicationethics.org/files/Code_of_conduct_for_journal_editors_Mar11.pdf
Further guidelines can also be found here: http://publicationethics.org/resources/guidelines

Article Processing Charges

Submit A Manuscript

Welcome to Editorial Manager ® for
Journal of Biopharmaceutics Sciences

Call for Papers

Journal of Biopharmaceutics Sciences (JBS) invites you to submit manuscripts for consideration in this scholarly journal. The journal welcomes research papers, reviews, reports and other manuscript types for the related interdisciplinary areas.

Journal of Biopharmaceutics Sciences (JBS) is empowered by eminent group of editors and reviewers. The board comprises eminent scholars with extensive publications.

The Editorial Board oversee the stringent multi-level Peer-Review process including evaluating submissions, selecting reviewers and assessing their comments and making editorial decisions.

Submit Your Queries

For any questions regarding academic publishing, please …

Send us an email to

We will get back to you in 24 hours. You can also contact us by sending your message to one of the following physical addresses:

VOLKSON PRESS SDN BHD
201701039525 (1253697-P)

C2-2-3, Block 2, CBD Perdana 3,
Persiaran Cyberpoint Timur,
Cyber 12, 63000 Cyberjaya,
Selangor
T: +603 8687 9842
F: +603 8686 1491